Akero Therapeutics - 53 Year Dividend History | AKRO
Historical dividend payout and yield for Akero Therapeutics (AKRO) since 1971. The current TTM dividend payout for Akero Therapeutics (AKRO) as of November 29, 2024 is $0.00. The current dividend yield for Akero Therapeutics as of November 29, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$2.241B |
$0.000B |
|
Akero Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing transformational treatments for non-alcoholic steatohepatitis and other serious metabolic disorders. The company's product pipeline consists of AKR-001, for the treatment of non-alcoholic steatohepatitis, which are in clinical stage. Akero Therapeutics Inc. is based in San Francisco, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
